Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_assertion type Assertion NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_head.
- NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_provenance.
- NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_assertion evidence source_evidence_literature NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_provenance.
- NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_assertion SIO_000772 12843792 NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_provenance.
- NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_assertion wasDerivedFrom befree-20140225 NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_provenance.
- NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_assertion wasGeneratedBy ECO_0000203 NP532822.RAn7qqtSF5P6l7iOI8ytVMC0q7BMsi66GjQuNfMn2eReQ130_provenance.